Swedish oncology firm Elekta of Stockholm has introduced two new products to treat lung tumors and enable doctors to visually confirm a tumor's position during the breathing cycle.
The new technology helps treat lesions with a continuous radiation beam, increasing therapy accuracy while using less imaging radiation during treatment delivery.
XVI Symmetry and XVI Intuity are featured in version 4.5 of Elekta's x-ray volume imaging (XVI) software for image-guided radiation therapy. XVI 4.5 recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the CE Mark in Europe.
Related Reading
Alexander to head Elekta's Asia-Pacific ops, March 29, 2010
Elekta posts 9% sales gain, March 15, 2010
Elekta wins Calif. VMAT contract, February 18, 2010
Elekta reaches VMAT milestone, February 12, 2010
UVA buys Elekta's Leksell, December 21, 2009
Copyright © 2010 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
